UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunogenicity of a xenogeneic multi-epitope HER2+ breast cancer DNA vaccine targeting the dendritic cell restricted antigen-uptake receptor DEC205

Vaccine, 2022-04, Vol.40 (16), p.2409-2419

2022

Volltextzugriff (PDF)

MANα1‐2MAN decorated liposomes enhance the immunogenicity induced by a DNA vaccine against BoHV‐1

Transboundary and emerging diseases, 2021-03, Vol.68 (2), p.587-597

2021

Volltextzugriff (PDF)

Enhanced humoral and CD8+ T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells

International immunopharmacology, 2017-05, Vol.46, p.62-69

2017

Volltextzugriff (PDF)

An all-in-one adjuvanted therapeutic cancer vaccine targeting dendritic cell cytosol induces long-lived tumor suppression through NLRC4 inflammasome activation

Biomaterials, 2022-07, Vol.286, p.121542-121542, Article 121542

2022

Volltextzugriff (PDF)

Enhanced immunity and antiviral effects of an HBV DNA vaccine delivered by a DC-targeting protein

Journal of viral hepatitis, 2016-10, Vol.23 (10), p.798-804

2016

Volltextzugriff (PDF)

Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses

Cell reports (Cambridge), 2022-05, Vol.39 (9), p.110901-110901, Article 110901

2022

Volltextzugriff (PDF)

Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy

International journal of molecular sciences, 2023-07, Vol.24 (15), p.12174

2023

Volltextzugriff (PDF)

Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance

Frontiers in immunology, 2021-05, Vol.12, p.674048

2021

Volltextzugriff (PDF)

Nanoparticle-based approaches to target the lymphatic system for antitumor treatment

Cellular and molecular life sciences : CMLS, 2021-06, Vol.78 (12), p.5139-5161

2021

Volltextzugriff (PDF)

Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells

Pharmaceutics, 2024-05, Vol.16 (5), p.581

2024

Volltextzugriff (PDF)

Understanding the Functional Properties of Neonatal Dendritic Cells: A Doorway to Enhance Vaccine Effectiveness?

Frontiers in immunology, 2019-01, Vol.9, p.3123-3123

2019

Volltextzugriff (PDF)

Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines

Frontiers in microbiology, 2022-08, Vol.13, p.937192-937192

2022

Volltextzugriff (PDF)

The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells

Vaccine, 2019-08, Vol.37 (35), p.4963-4974

2019

Volltextzugriff (PDF)

The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells

Biomaterials, 2011-10, Vol.32 (28), p.6791-6803

2011

Volltextzugriff (PDF)

Magnetic Enrichment of Dendritic Cell Vaccine in Lymph Node with Fluorescent-Magnetic Nanoparticles Enhanced Cancer Immunotherapy

Theranostics, 2016-01, Vol.6 (11), p.2000-2014

2016

Volltextzugriff (PDF)

Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity

Biomaterials, 2020-12, Vol.262, p.120342-120342, Article 120342

2020

Volltextzugriff (PDF)

Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses

Frontiers in immunology, 2020-05, Vol.11, p.990-990

2020

Volltextzugriff (PDF)

A novel "prime and pull" strategy mediated by the combination of two dendritic cell-targeting designs induced protective lung tissue-resident memory T cells against H1N1 influenza virus challenge

Journal of nanobiotechnology, 2023-12, Vol.21 (1), p.479-479, Article 479

2023

Volltextzugriff (PDF)

A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice

Immunology letters, 2015-12, Vol.168 (2), p.293-299

2015

Volltextzugriff (PDF)

Aptamer-Functionalized Nanovaccines: Targeting In Vivo DC Subsets for Enhanced Antitumor Immunity

ACS applied materials & interfaces, 2023-04, Vol.15 (15), p.18590-18597

2023

Volltextzugriff (PDF)

Innate immunity in DNA vaccine with Toxoplasma gondii -heat shock protein 70 gene that induces DC activation and Th1 polarization

Vaccine, 2011-02, Vol.29 (10), p.1899-1905

2011

Volltextzugriff (PDF)

Targeted Delivery of Vaccine to Dendritic Cells by Chitosan Nanoparticles Conjugated with a Targeting Peptide Ligand Selected by Phage Display Technique

Macromolecular bioscience, 2015-03, Vol.15 (3), p.395-404

2015

Volltextzugriff (PDF)

In vivo targeting of porcine reproductive and respiratory syndrome virus antigen through porcine DC-SIGN to dendritic cells elicits antigen-specific CD4T cell immunity in pigs

Vaccine, 2014-11, Vol.32 (50), p.6768-6775

2014

Volltextzugriff (PDF)

Dendritic cell-targeted porcine reproductive and respiratory syndrome virus (PRRSV) antigens adjuvanted with polyinosinic-polycytidylic acid (poly (I:C)) induced non-protective immune responses against heterologous type 2 PRRSV challenge in pigs

Veterinary immunology and immunopathology, 2017-08, Vol.190, p.18-25

2017

Volltextzugriff (PDF)

Development of an epitope-based HIV-1 vaccine strategy from HIV-1 lipopeptide to dendritic-based vaccines

Expert review of vaccines, 2017-10, Vol.16 (10), p.955-972

2017

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(37)
Buchkapitel
(1)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunogenicity of a xenogeneic multi-epitope HER2+ breast cancer DNA vaccine targeting the dendritic cell restricted antigen-uptake receptor DEC205

MANα1‐2MAN decorated liposomes enhance the immunogenicity induced by a DNA vaccine against BoHV‐1

Enhanced humoral and CD8+ T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells

An all-in-one adjuvanted therapeutic cancer vaccine targeting dendritic cell cytosol induces long-lived tumor suppression through NLRC4 inflammasome activation

Enhanced immunity and antiviral effects of an HBV DNA vaccine delivered by a DC-targeting protein

Antigen bivalency of antigen-presenting cell-targeted vaccines increases B cell responses

Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy

Therapeutic Liposomal Vaccines for Dendritic Cell Activation or Tolerance

Nanoparticle-based approaches to target the lymphatic system for antitumor treatment

Vaccination with DC-SIGN-Targeting αGC Liposomes Leads to Tumor Control, Irrespective of Suboptimally Activated T-Cells

Understanding the Functional Properties of Neonatal Dendritic Cells: A Doorway to Enhance Vaccine Effectiveness?

Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines

The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells

The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells

Magnetic Enrichment of Dendritic Cell Vaccine in Lymph Node with Fluorescent-Magnetic Nanoparticles Enhanced Cancer Immunotherapy

Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity

Lipo-Based Vaccines as an Approach to Target Dendritic Cells for Induction of T- and iNKT Cell Responses

A novel "prime and pull" strategy mediated by the combination of two dendritic cell-targeting designs induced protective lung tissue-resident memory T cells against H1N1 influenza virus challenge

A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice

Aptamer-Functionalized Nanovaccines: Targeting In Vivo DC Subsets for Enhanced Antitumor Immunity

Innate immunity in DNA vaccine with Toxoplasma gondii -heat shock protein 70 gene that induces DC activation and Th1 polarization

Targeted Delivery of Vaccine to Dendritic Cells by Chitosan Nanoparticles Conjugated with a Targeting Peptide Ligand Selected by Phage Display Technique

In vivo targeting of porcine reproductive and respiratory syndrome virus antigen through porcine DC-SIGN to dendritic cells elicits antigen-specific CD4T cell immunity in pigs

Dendritic cell-targeted porcine reproductive and respiratory syndrome virus (PRRSV) antigens adjuvanted with polyinosinic-polycytidylic acid (poly (I:C)) induced non-protective immune responses against heterologous type 2 PRRSV challenge in pigs

Development of an epitope-based HIV-1 vaccine strategy from HIV-1 lipopeptide to dendritic-based vaccines

Suchergebnisse filtern